NCT07609862

A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2026-05-30Est. Completion: 2029-06-30

Enrollment target: 92 participants

Contact

Lugui Qiuqiulg@ihcams.ac.cn +86-13821266636

Other microbiome trials you might be interested in

Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell LymphomaPhase 2TERMINATED

Mantle Cell Lymphoma

The proposed study is an open-label, single arm phase II study of venetoclax in combination with rituximab in patients o…

Baltimore, United StatesCompleted May 14, 2025

View Trial →

Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell LymphomaPhase 2Completed

Contiguous Stage II Mantle Cell LymphomaNoncontiguous Stage II Mantle Cell LymphomaStage I Mantle Cell LymphomaStage III Mantle Cell LymphomaStage IV Mantle Cell Lymphoma

This study is being done to see whether or not a drug called ibrutinib can be given to patients with mantle cell lymphom…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.